Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy

Beta-adrenoreceptor blockers are widely used in the treatment of various cardiovascular diseases. The review discusses the benefits of a highly selective beta-adrenoblocker betaxolol in patients with coronary heart disease, arterial hypertension, cardiac arrhythmias, and chronic heart failure. Possi...

Full description

Saved in:
Bibliographic Details
Main Author: D. V. Duplyakov
Format: Article
Language:Russian
Published: «SILICEA-POLIGRAF» LLC 2009-08-01
Series:Кардиоваскулярная терапия и профилактика
Subjects:
Online Access:https://cardiovascular.elpub.ru/jour/article/view/1831
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850028200121335808
author D. V. Duplyakov
author_facet D. V. Duplyakov
author_sort D. V. Duplyakov
collection DOAJ
description Beta-adrenoreceptor blockers are widely used in the treatment of various cardiovascular diseases. The review discusses the benefits of a highly selective beta-adrenoblocker betaxolol in patients with coronary heart disease, arterial hypertension, cardiac arrhythmias, and chronic heart failure. Possible adverse effects are also discussed, including metabolic, bronchial, and lactation-related ones.
format Article
id doaj-art-72fdd97075bb4b8e8a80fed4bb90f8a5
institution DOAJ
issn 1728-8800
2619-0125
language Russian
publishDate 2009-08-01
publisher «SILICEA-POLIGRAF» LLC
record_format Article
series Кардиоваскулярная терапия и профилактика
spelling doaj-art-72fdd97075bb4b8e8a80fed4bb90f8a52025-08-20T02:59:53Zrus«SILICEA-POLIGRAF» LLCКардиоваскулярная терапия и профилактика1728-88002619-01252009-08-01841031121546Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapyD. V. Duplyakov0Samara Region Cardiology DispanserBeta-adrenoreceptor blockers are widely used in the treatment of various cardiovascular diseases. The review discusses the benefits of a highly selective beta-adrenoblocker betaxolol in patients with coronary heart disease, arterial hypertension, cardiac arrhythmias, and chronic heart failure. Possible adverse effects are also discussed, including metabolic, bronchial, and lactation-related ones.https://cardiovascular.elpub.ru/jour/article/view/1831cardiovascular diseasebeta-adrenoblockersbetaxolol
spellingShingle D. V. Duplyakov
Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
Кардиоваскулярная терапия и профилактика
cardiovascular disease
beta-adrenoblockers
betaxolol
title Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
title_full Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
title_fullStr Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
title_full_unstemmed Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
title_short Cardioselective beta-adrenoreceptor blockade with betaxolol in cardiovascular therapy
title_sort cardioselective beta adrenoreceptor blockade with betaxolol in cardiovascular therapy
topic cardiovascular disease
beta-adrenoblockers
betaxolol
url https://cardiovascular.elpub.ru/jour/article/view/1831
work_keys_str_mv AT dvduplyakov cardioselectivebetaadrenoreceptorblockadewithbetaxololincardiovasculartherapy